Plain-English translation of NCT07806695 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Researchers at Mayo Clinic want to understand how the pancreas changes during pregnancy and after delivery, particularly in people who develop gestational diabetes. By studying two groups of pregnant people—those who develop gestational diabetes and those who don't—scientists hope to learn more about what causes this condition and how the body recovers after pregnancy.
Gestational diabetes affects many pregnant people, but doctors still don't fully understand why some women develop it while others don't. Learning more about how the pancreas functions during this time could help improve care and prevention strategies in the future.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll attend visits during your pregnancy and again after delivery to have blood tests and metabolic measurements taken. The researchers will compare your pancreas function over time with other pregnant participants, either those who developed gestational diabetes or those who didn't. The study is designed to last through your pregnancy and into the postpartum period, with specific visits scheduled at key timepoints.
AI-generated summary from trial data · Sep 19, 2026 · Not medical advice
United States
Phase
Safety & dosing
Sponsor
Mayo Clinic
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrollment target
~90 participants
Started
September 2026
Primary completion
March 2030
Age range
20 Years – 40 Years
Sex
Female only
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jeanette Laugen
Mayo Clinic
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.